ScholarIQanswers from OpenAlex & ORCID
Aňa Lluch
ResearcherPublications, citations & collaboration network
Aňa Lluch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Aňa Lluch have?
ScholarIQindexed works
Aňa Lluch has 790 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Aňa Lluch have?
ScholarIQcitation count
Aňa Lluch has 24,963 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Aňa Lluch?
ScholarIQh-index
Aňa Lluch has an h-index of 73 in OpenAlex.
What is the i10-index of Aňa Lluch?
ScholarIQi10-index
Aňa Lluch has an i10-index of 250 in OpenAlex.
What is the ORCID of Aňa Lluch?
ScholarIQorcid
The ORCID for Aňa Lluch is on the source record.
What is the OpenAlex record for Aňa Lluch?
ScholarIQopenalex
The OpenAlex for Aňa Lluch is on the source record.
What are the most-cited papers on Aňa Lluch?
ScholarIQmost cited works
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Luca Gianni, W. Eiermann, Semiglazov Vf, Alexey Manikhas, Aňa Lluch, S. Tjulandin, Milvia Zambetti, Federico Vázquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Ángel Climent, Eva Ciruelos, B. Ojeda, Mauro Mansutti, А. А. Божок, Roberta Baronio, A. Feyereislova, Claire Barton, Pinuccia Valagussa, José Baselga
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee, Jane Fridlyand, Ayşegül A. Şahin, Roshan Agarwal, Corwin Joy, Wenbin Liu, David Stivers, Keith Baggerly, Mark Carey, Aňa Lluch, Carlos Monteagudo, Xiaping He, Victor Weigman, Cheng Fan, Juan Palazzo, Gabriel N. Hortobágyi, Laura K. Nolden, Nicholas J. Wang, Vicente Valero, Joe W. Gray, Charles M. Perou, Gordon B. Mills
Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
Luca Gianni, José Baselga, W. Eiermann, Vincente Guillem Porta, Semiglazov Vf, Aňa Lluch, Milvia Zambetti, Dolores Sabadell, Günther Raab, Antonio Llombart‐Cussac, А. А. Божок, Ángel Martínez-Agulló, Marco Greco, Mikhail Byakhov, Juan José López Gómez, Mauro Mansutti, Pinuccia Valagussa, Gianni Bonadonna
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study
Adela Castelló, Marina Pollán, Brian Buijsse, A. Ruíz, Ana Casas, José Manuel Baena-Cañada, Virginia Lope, Silvia Antolín, Manuel Ramos, Montserrat Muñoz-Mateu, Aňa Lluch, Ana de Juan-Ferré, Carlos Jara, M. Jimeno, Petra Rosado, Elena Dı́az, Vicente Guillém, Eva Carrasco, Beatriz Pérez‐Gómez, Jesús Vioqué, Heiner Boeing, Miguel Martín
Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy
Luca Gianni, José Baselga, W. Eiermann, V. Guillem Porta, Semiglazov Vf, Aňa Lluch, Milvia Zambetti, Dolores Sabadell, Günther Raab, Antonio Llombart‐Cussac, А. А. Божок, Ángel Martínez-Agulló, Marco Greco, Mikhail Byakhov, Juan José López Gómez, Mauro Mansutti, Pinuccia Valagussa, Gianni Bonadonna, European Cooperative Trial in Operable Breast Cancer Study Group